ArticleDiabetes, obesity & metabolism2025

Adherence to GLP-1 receptor agonists and SGLT2 inhibitors by out-of-pocket spending among Medicare beneficiaries with diabetes.

Nicklas S Klepser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.